{
  "meta": {
    "title": "8_Antenatal_Investigations",
    "url": "https://brainandscalpel.vercel.app/8-antenatal-investigations-0ad89b8e.html",
    "scrapedAt": "2025-11-30T12:30:11.368Z"
  },
  "questions": [
    {
      "text": "Which of the following statements is false about non-invasive prenatal testing?",
      "choices": [
        {
          "id": 1,
          "text": "It uses cell-free circulating fetal DNA in the maternal serum"
        },
        {
          "id": 2,
          "text": "It is used for the diagnosis of trisomy 13, 18 and 21"
        },
        {
          "id": 3,
          "text": "It can be performed after 10 weeks of gestation"
        },
        {
          "id": 4,
          "text": "It is done after the routine first trimester ultrasound assessment"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Non-invasive prenatal testing (<strong>NIPT</strong>) is used for the <strong>screening</strong> of <strong>trisomy 13, 18</strong> and <strong>21</strong> and <strong>Turner's</strong> syndrome. It is not a diagnostic test.</p>\n<p>It is a novel genetic test that uses <strong>cell-free circulating fetal DNA </strong>in the<strong> maternal serum</strong> for screening of chromosomal anomalies. </p>\n<p>DNA from the fetus is found circulating in the maternal blood in two forms - either inside the intact fetal cells or as cell-free DNA from the breakdown of placental fetal cells. In NIPT, the cell-free chromosome fragments are measured and the quantitative differences from normal fetuses are noted.</p>\n<p>NIPT can be performed <strong>after 10 weeks</strong> of gestation and is recommended after the routine first-trimester ultrasound assessment in <strong>high-risk pregnancies</strong> or if either <strong>1st or 2nd-trimester</strong> screening becomes <strong>positive.</strong> Its disadvantage is that it is very <strong>expensive</strong> and it can be used for screening of only a few chromosomal anomalies such as trisomy 13, 18, and 21 and it doesn't analyse the entire karyotype.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4557",
      "difficulty": "hard"
    },
    {
      "text": "A pregnant woman has a fetus with Down's syndrome. Triple test done at 15-16 weeks will have ______.",
      "choices": [
        {
          "id": 1,
          "text": "Low MSAFP, high hCG, low UE3"
        },
        {
          "id": 2,
          "text": "High MSAFP, low hCG, high UE3"
        },
        {
          "id": 3,
          "text": "Low MSAFP,  high hCG, high UE3"
        },
        {
          "id": 4,
          "text": "High MSAFP, low hCG, low UE3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The triple test findings in pregnancies with fetal <strong>Down’s syndrome</strong> are characterized by:</p>\n<ul>\n<li><strong>Low MSAFP</strong> (maternal serum alpha-fetoprotein) levels, approximately 0.7 MoM (multiples of median).</li>\n<li><strong>Low unconjugated</strong> <strong>estriol</strong> levels, approximately 0.8 MoM.</li>\n<li><strong>High hCG</strong> levels, approximately 2.0 MoM.</li>\n</ul>\n<p>The triple test is done between <strong>15-18 weeks</strong> for the diagnosis of Down's syndrome. </p>\n<p>Various antenatal screening tests for aneuploidy are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Dual test (1<sup>st</sup> trimester)</strong></td>\n<td><strong>Triple test (2<sup>nd</sup> trimester)</strong></td>\n<td><strong>Quadruple test (2<sup>nd</sup> trimester)</strong></td>\n</tr>\n<tr>\n<td>Beta HCG </td>\n<td>Beta HCG </td>\n<td>Beta HCG </td>\n</tr>\n<tr>\n<td>PAPPA </td>\n<td>Unconjugated estriol </td>\n<td>Unconjugated estriol </td>\n</tr>\n<tr>\n<td rowspan=\"2\">This can be combined with nuchal translucency by USG</td>\n<td>MSAFP </td>\n<td>MSAFP </td>\n</tr>\n<tr>\n<td> </td>\n<td>Serum <strong>inhibin A</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>First-trimester screening with biochemical analytes <strong>(↓) PAPP-A and (↑) hCG and USG measurement of NT (↑)</strong> can improve the detection rate (87%) of Down’s syndrome. For confirmation, a prenatal genetic study (CVS, amniocentesis or cordo\u0002centesis) has to be performed.</p>\n<p>Second-trimester screening (quad screening) at 15–18 weeks: <strong>(↓) MSAFP, (↓) uE3, (↑) inhibin A and (↑) hCG</strong> can detect trisomy 21 in 85% of cases with a false-positive rate of 0.9%. When it is combined with first-trimester screening, the detection rate is increased to 95%.</p>\n<p> </p><p>World Down Syndrome Day (WDSD) on March 21 is an important day recognized worldwide, observed by the United Nations since 2012. The theme is \"End The Stereotypes.\" It's a call to action for everyone worldwide to challenge and break down the stereotypes surrounding Down syndrome.</p><hr><h3>Related Pearl: Prenatal screening for Down’s syndrome</h3><ul>\n<li><strong>USG findings</strong>\n<ul>\n<li>Intrauterine growth retardation (so decreased blood flow)</li>\n<li>Choroid plexus cysts</li>\n<li>Increased <strong>nuchal translucency &gt;3 mm</strong></li>\n<li>Hypoplastic nasal bone</li>\n<li>Congenital heart defects</li>\n<li>Increased intestinal echogenicity</li>\n<li>Duodenal atresia</li>\n</ul>\n</li>\n<li><strong>Maternal serum markers</strong>\n<ul>\n<li>Decreased: Alpha-fetoprotein (AFP), unconjugated estriol, pregnancy-associated plasma protein-A (PAPP-A)</li>\n<li>Increased: Human chorionic gonadotrophin (HCG), inhibin, neutrophil alkaline phosphatase</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Amniocentesis</strong>: 14<sup>th</sup>-18<sup>th</sup> week of pregnancy</li>\n<li><strong>Chorionic villus sampling</strong>\n<ul>\n<li>10<sup>th</sup> to 12<sup>th</sup> week of pregnancy: Gives the&nbsp;diagnosis in the&nbsp;first trimester</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9208",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not included in the quadruple screening test?",
      "choices": [
        {
          "id": 1,
          "text": "Inhibin B"
        },
        {
          "id": 2,
          "text": "Unconjugated Estriol (E3)"
        },
        {
          "id": 3,
          "text": "AFP"
        },
        {
          "id": 4,
          "text": "hCG"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Inhibin B&nbsp;</strong>is not a component assayed under the quad-screening test. <strong>Dimeric inhibin-A</strong> is evaluated in this screening test.</p>\n<p><strong>Quadruple testing</strong>&nbsp;is done in the&nbsp;<strong>second trimester&nbsp;</strong>between<strong>&nbsp;15-21 weeks&nbsp;</strong>of gestation.&nbsp;It comprises:</p>\n<ul>\n<li>Maternal serum AFP</li>\n<li>Human chorionic gonadotropin</li>\n<li>Unconjugated estriol (E3)</li>\n<li>Dimeric inhibin A</li>\n</ul>\n<p>The following table summarizes the findings of the quad-screening test in various conditions.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Trisomy 21</strong></td>\n<td><strong>Trisomy 18</strong></td>\n<td><strong>Neural tube defect or abdominal wall defect</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MSAFP</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td><strong>&beta; hCG</strong></td>\n<td>High</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Unconjugated estriol</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Inhibin A</strong></td>\n<td>High</td>\n<td>Normal/Low</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Various antenatal screening tests for aneuploidy are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Dual test (1<sup>st</sup>&nbsp;trimester)</strong></td>\n<td><strong>Triple test (2<sup>nd</sup>&nbsp;trimester)</strong></td>\n<td><strong>Quadruple test <br />(2<sup>nd&nbsp;</sup>trimester)</strong></td>\n</tr>\n<tr>\n<td>\n<p>1. Beta HCG&nbsp;<br /><br />2.&nbsp;PAPPA (Pregnancy-associated plasma protein A)<br /><br />This can be combined with nuchal translucency by USG</p>\n</td>\n<td>\n<p>1. Beta HCG&nbsp;<br /><br />2. Unconjugated estriol&nbsp;<br /><br />3. MSAFP&nbsp;&nbsp;</p>\n</td>\n<td>\n<p>1. Beta HCG&nbsp;<br /><br />2. Unconjugated estriol&nbsp;<br /><br />3. MSAFP&nbsp;<br /><br />4. Serum inhibin&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Prenatal screening for Down’s syndrome</h3><ul>\n<li><strong>USG findings</strong>\n<ul>\n<li>Intrauterine growth retardation (so decreased blood flow)</li>\n<li>Choroid plexus cysts</li>\n<li>Increased <strong>nuchal translucency &gt;3 mm</strong></li>\n<li>Hypoplastic nasal bone</li>\n<li>Congenital heart defects</li>\n<li>Increased intestinal echogenicity</li>\n<li>Duodenal atresia</li>\n</ul>\n</li>\n<li><strong>Maternal serum markers</strong>\n<ul>\n<li>Decreased: Alpha-fetoprotein (AFP), unconjugated estriol, pregnancy-associated plasma protein-A (PAPP-A)</li>\n<li>Increased: Human chorionic gonadotrophin (HCG), inhibin, neutrophil alkaline phosphatase</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Amniocentesis</strong>: 14<sup>th</sup>-18<sup>th</sup> week of pregnancy</li>\n<li><strong>Chorionic villus sampling</strong>\n<ul>\n<li>10<sup>th</sup> to 12<sup>th</sup> week of pregnancy: Gives the&nbsp;diagnosis in the&nbsp;first trimester</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0558",
      "difficulty": "easy"
    },
    {
      "text": "Quadruple testing is done during:",
      "choices": [
        {
          "id": 1,
          "text": "9-11 weeks"
        },
        {
          "id": 2,
          "text": "12-14 weeks"
        },
        {
          "id": 3,
          "text": "15-20 weeks"
        },
        {
          "id": 4,
          "text": "22-28 weeks"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The <strong>quadruple screening test</strong> is ideally done in the second trimester, during <strong>15-20 weeks</strong> of gestation. The most <strong>accurate</strong> values are seen during <strong>16-18 weeks</strong> of gestation.&nbsp;</p>\n<p>It is the measurement of maternal serum alpha-fetoprotein (MSAFP), unconjugated estriol, hCG, and inhibin-A.&nbsp;</p>\n<p>In Down's syndrome (trisomy 21) or Edward's syndrome (trisomy 18), quadruple-marker screenings do not provide any added benefit over first-trimester screenings. It is generally used as a stand-alone test if screening is done for the first time in the second trimester or if first-trimester screening is not available.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Trisomy 21</strong></td>\n<td><strong>Trisomy 18</strong></td>\n<td><strong>Neural tube defect or abdominal wall defect</strong></td>\n<td><strong>Trisomy 13/ Patau syndrome</strong></td>\n</tr>\n<tr>\n<td><strong>MSAFP</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td><strong>High</strong></td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>&beta; hCG</strong></td>\n<td><strong>High</strong></td>\n<td>Low</td>\n<td>Normal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>Unconjugated estriol</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n<td>&nbsp;Normal</td>\n</tr>\n<tr>\n<td><strong>Inhibin A</strong></td>\n<td><strong>High</strong></td>\n<td>Normal/Low</td>\n<td>Normal</td>\n<td>&nbsp;<strong>High</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4285",
      "difficulty": "medium"
    },
    {
      "text": "Results of the quadruple screening test are tabulated below for three congenital anomalies. Choose the correctly matched set.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>1</strong></td>\n<td><strong>2</strong></td>\n<td><strong>3</strong></td>\n</tr>\n<tr>\n<td>Maternal serum alpha-fetoprotein (MSAFP)</td>\n<td>Low</td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td>&nbsp;Human chorionic gonadotropin (&beta;-hCG)</td>\n<td>High</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Unconjugated estriol</td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>Inhibin A</td>\n<td>High</td>\n<td>Normal/Low</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1- Trisomy 21; 2- Trisomy 18; 3- Neural tube defect"
        },
        {
          "id": 2,
          "text": "1- Trisomy 18; 2- Trisomy 21; 3- Neural tube defect"
        },
        {
          "id": 3,
          "text": "1- Trisomy 21; 2-  Neural tube defect; 3- Trisomy 18"
        },
        {
          "id": 4,
          "text": "1- Trisomy 18; 2- Trisomy 13; 3- Neural tube defect"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Quadruple testing is done in the <strong>second trimester between 15-21 weeks </strong>of gestation and involves the following parameters:</p>\n<ul>\n<li>Maternal serum alpha fetal protein (MSAFP)&nbsp;</li>\n<li>&beta; hCG</li>\n<li>Unconjugated estriol</li>\n<li>Inhibin A</li>\n</ul>\n<table>\n<tbody>\n<tr>\n<td><strong>Parameter</strong></td>\n<td><strong>Trisomy 21/ Downs syndrome</strong></td>\n<td><strong>Trisomy 18/ Edward syndrome</strong></td>\n<td><strong>Neural tube defect or abdominal wall defect</strong>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>MSAFP</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td><strong>High</strong></td>\n</tr>\n<tr>\n<td><strong>&beta; hCG</strong></td>\n<td>High</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Unconjugated estriol</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Inhibin A</strong></td>\n<td>High</td>\n<td>Normal/Low</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0361",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following conditions is an increased level of alpha fetoprotein seen?",
      "choices": [
        {
          "id": 1,
          "text": "Gestational trophoblastic diseases"
        },
        {
          "id": 2,
          "text": "Molar pregnancy"
        },
        {
          "id": 3,
          "text": "Under estimated gestational age"
        },
        {
          "id": 4,
          "text": "Spontaneous abortion"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In underestimated gestational age, there is an increased level of maternal serum alpha fetoprotein (MSAFP).</p>\n<p><strong>Elevated</strong> levels of MSAFP are seen in:</p>\n<ul>\n<li>Underestimated gestational age</li>\n<li>Severe oligohydramnios</li>\n<li>Multifetal pregnancy</li>\n<li>Neural tube defects</li>\n<li>Abdominal wall defects- Omphalocele, Gastroschisis</li>\n<li>Hepatoma</li>\n<li>Endodermal sinus tumour</li>\n</ul>\n<p><strong>Reduced</strong> levels of MSAFP are seen in:</p>\n<ul>\n<li>Overestimated gestational age</li>\n<li>Overweight mother</li>\n<li>Gestational trophoblastic diseases</li>\n<li>Spontaneous abortion</li>\n<li>Trisomy 18 and 21&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9799",
      "difficulty": "hard"
    },
    {
      "text": "Increased maternal serum alpha-fetoprotein is detected in a primigravida. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Repeat measurement of MSAFP at a later date"
        },
        {
          "id": 2,
          "text": "Targeted sonography"
        },
        {
          "id": 3,
          "text": "Amniocentesis"
        },
        {
          "id": 4,
          "text": "Termination of pregnancy"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The next best step is&nbsp;<strong>targeted sonography</strong>. Maternal serum alpha-fetoprotein (MSAFP) levels are only used as a screening test and must be followed by a diagnostic test.</p>\n<p><strong>Amniocentesis</strong> is a diagnostic test for amniotic fluid AFP measurement. It was once considered the standard for the diagnosis of open neural tube disorders but has been <strong>replaced</strong> in most centers <strong>by</strong> <strong>targeted sonography.</strong></p>\n<p>Defects in fetal integuments, such as ventral wall and <strong>neural tube defects</strong>, permit fetal AFP to leak into the amnionic fluid. This results in&nbsp;<strong>increased</strong> <strong>MSAFP</strong> levels. This is detected on screening performed from <strong>15 to 20 weeks</strong> of gestation.</p>\n<div class=\"page\" title=\"Page 303\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 304\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Conditions with <strong>elevated MSAFP</strong>:</p>\n<ul>\n<li>Wrong gestational age</li>\n<li>Neural tube defects</li>\n<li>Multiple pregnancies</li>\n<li>Renal anomalies</li>\n</ul>\n<p>Conditions with <strong>decreased MSAFP</strong>:</p>\n<ul>\n<li>Trisomies (Down's syndrome)</li>\n<li>Gestational trophoblastic disease.</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5701",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding alpha fetoprotein?",
      "choices": [
        {
          "id": 1,
          "text": "MSAFP is detected at 16-18 weeks of gestation"
        },
        {
          "id": 2,
          "text": "Diabetic patients have increased AFP levels"
        },
        {
          "id": 3,
          "text": "MSAFP is unrelated to period of gestation"
        },
        {
          "id": 4,
          "text": "Lowest fetal AFP is seen around 13 weeks of gestation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The maternal serum AFP screening is generally performed from <strong>15-20 weeks</strong> of gestation. Hence, it is detected in this period.</p>\n<p>Alpha-fetoprotein (AFP) is the major serum protein in the embryo and fetus. It is produced by the yolk sac and fetal liver.&nbsp;</p>\n<p>Option B: <strong>Diabetic</strong> patients have <strong>low</strong> levels of AFP.&nbsp;</p>\n<p>Option C: Gestational age influences the <strong>MSAFP</strong> levels. The maternal serum concentration <strong>increases</strong> by approximately 15% per week during the <strong>second trimester</strong>.</p>\n<p>Option D: At about <strong>13 weeks</strong> of gestation, the <strong>AFP</strong> concentration in the <strong>fetal</strong> serum and amniotic fluid are <strong>highest</strong>, after which it declines.&nbsp;Conversely, AFP is found in steadily increasing quantities in maternal serum after 12 weeks.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5766",
      "difficulty": "medium"
    },
    {
      "text": "During genetic counseling, a pregnant woman states that both she and her husband have sickle cell trait. You offer the option of chorionic villus sampling for prenatal diagnosis. What is the best time to perform this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "6-8 weeks"
        },
        {
          "id": 2,
          "text": "7-9 weeks"
        },
        {
          "id": 3,
          "text": "9-10 weeks"
        },
        {
          "id": 4,
          "text": "11-13 weeks"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The best time to perform chorionic villous sampling is <strong>11-13 weeks.</strong></p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Chorionic villus sampling:</strong></p>\n</td>\n</tr>\n<tr>\n<td>Study material</td>\n<td>\n<p>Chorionic villi from trophoblastic cells</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Time</p>\n</td>\n<td>\n<p>10 to 13 weeks<strong>&nbsp;</strong>(transcervically)</p>\n<p>10 weeks to term (transabdominally)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Indications</p>\n</td>\n<td>\n<p>To detect chromosomal abnormalities such as Down syndrome.</p>\n<p>To detect inborn errors of metabolism like phenylketonuria.</p>\n<p>For DNA analysis in hemoglobinopathies, thalassemia, and sickle cell anemia.</p>\n</td>\n</tr>\n<tr>\n<td>Complications</td>\n<td>\n<p>Abortion (CVS&gt; Amniocentesis)</p>\n<p>Limb reduction defects and oro-mandibular defects&nbsp;(when done before 10 weeks)</p>\n</td>\n</tr>\n<tr>\n<td>Drawback</td>\n<td>\n<p>Not suitable for the detection of neural tube defects.</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9797",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not true about amniocentesis?",
      "choices": [
        {
          "id": 1,
          "text": "Traditionally done between 16-20 weeks"
        },
        {
          "id": 2,
          "text": "Limb reduction defect is a known complication"
        },
        {
          "id": 3,
          "text": "Down's syndrome can be diagnosed"
        },
        {
          "id": 4,
          "text": "Approximately 20 to 30 mL is collected for fetal karyotyping"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Limb reduction defect</strong> is a complication of <strong>chorionic villous sampling</strong>.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Amniocentesis</strong></td>\n</tr>\n<tr>\n<td>Study material</td>\n<td>Amniotic fluid with amniocytes</td>\n</tr>\n<tr>\n<td>Time</td>\n<td>16-20 weeks</td>\n</tr>\n<tr>\n<td>Early amniocentesis</td>\n<td>\n<p>11-14 weeks (associated with increased fetal loss, foot deformities)</p>\n</td>\n</tr>\n<tr>\n<td>Diagnostic indications</td>\n<td>Sex-linked disorders, karyotyping, inborn errors of metabolism, neural tube defects</td>\n</tr>\n<tr>\n<td>Therapeutic&nbsp;indications</td>\n<td>Abortion induction, decompression of uterus in acute hydramnios, amnioinfusion in oligohydramnios</td>\n</tr>\n<tr>\n<td>Procedure</td>\n<td>\n<p>Under direct sonographic guidance, a <strong>20&ndash;22 gauge spinal needle</strong>&nbsp;is directed into a clear pocket of amniotic fluid while avoiding the fetus and umbilical cord.</p>\n<p>Approximately 20 to 30 mL of fluid is collected.</p>\n</td>\n</tr>\n<tr>\n<td>Complication</td>\n<td>Chorioamnionitis, premature Rupture Of Membranes (PROM), fetal trauma/loss, fetomaternal hemorrhage.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9798",
      "difficulty": "medium"
    },
    {
      "text": "A 28-year-old woman presents with 6 weeks of amenorrhea and a positive urine pregnancy test. She states her brother had cystic fibrosis and asks if her child might have the same. Which of the following methods would not be useful for prenatal diagnosis of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Amniocentesis"
        },
        {
          "id": 2,
          "text": "Cordocentesis"
        },
        {
          "id": 3,
          "text": "Chorionic villous sampling"
        },
        {
          "id": 4,
          "text": "Fetal skin biopsy"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Fetal skin biopsy is not a recommended method of prenatal diagnosis of cystic fibrosis. It is done to detect inherited skin conditions such as:</p>\n<ul>\n<li>Ichthyosis</li>\n<li>Epidermolysis bullosa</li>\n<li>Oculocutaneous albinism</li>\n</ul>\n<p>Invasive procedures for <strong>prenatal diagnosis</strong> of<strong> CFTR gene mutations</strong>&nbsp;in cystic fibrosis include:</p>\n<ul>\n<li>Chorionic villus sampling (CVS)</li>\n<li>Amniocentesis</li>\n<li>Cordocentesis or percutaneous umbilical blood sampling (PUBS)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5735",
      "difficulty": "medium"
    },
    {
      "text": "A G2P1 woman at 35 weeks of pregnancy presents with complaints of decreased fetal movement. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Observation"
        },
        {
          "id": 2,
          "text": "Non-stress test"
        },
        {
          "id": 3,
          "text": "Biophysical profile"
        },
        {
          "id": 4,
          "text": "Induce labour"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In case of reduced fetal movements, the first step of management is to do a <strong>non-stress test</strong> (NST).</p>\n<p>Interpretation of NST:</p>\n<ul>\n<li>Reactive<strong>&nbsp;</strong>\n<ul>\n<li>&ge;<strong>2 accelerations </strong>of<strong> &gt;15 beats/minute</strong>&nbsp;above the baseline and <strong>longer than 15 seconds</strong> in duration are present in a<strong> 20-minute observation</strong></li>\n<li>Reassure the patient and send back home</li>\n</ul>\n</li>\n<li>Non-reactive - biophysical profile (BPP) has to be assessed.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5690",
      "difficulty": "easy"
    },
    {
      "text": "The CTG shown in the image below may be seen in which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Head compression"
        },
        {
          "id": 2,
          "text": "Cord compression"
        },
        {
          "id": 3,
          "text": "Fetal hypoxia"
        },
        {
          "id": 4,
          "text": "Normal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given CTG shows<strong> early deceleration </strong>which is seen in cases of <strong>head</strong> <strong>compression</strong>.</p><hr><h3>Related Pearl: Deceleration patterns on cardiotocography (CTG)</h3><p><strong>Early deceleration</strong>: seen in head compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01ca2f6239b443139c19f8cfb251123fx720x612.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Late deceleration</strong>:&nbsp;Seen in uteroplacental insufficiency, foetal hypoxia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d22f1efb031f427abc29cb814976ea47x468x323.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Variable</strong> <strong>deceleration</strong>: Seen in umbilical cord compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/034553eba0b7498882645a4cf156f0e0x468x399.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/01c817aaf54f49cfa4672641761b4a2d.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9435",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old G2P1 at 38 weeks of gestation came to the labor room with complaints of decreased fetal movements. Non-stress test was done and late decelerations were noted. What does this indicate?",
      "choices": [
        {
          "id": 1,
          "text": "Head compression"
        },
        {
          "id": 2,
          "text": "Cord compression"
        },
        {
          "id": 3,
          "text": "Fetal hypoxia"
        },
        {
          "id": 4,
          "text": "Breech presentation"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of&nbsp;<strong>fetal hypoxia. </strong>Late decelerations are seen on an NST in this condition.</p>\n<p>Deceleration is a decrease in fetal heart rate below the baseline by 15 bpm for more than 15 seconds. <strong>Absent variability</strong> <strong>of FHR</strong> with <strong>late decelerations</strong> is an indication for <strong>immediate Cesarean section</strong>.&nbsp;&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4e7ae8243928483a95ce260ed45c1a06x1200x1203.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Deceleration patterns on cardiotocography (CTG)</h3><p><strong>Early deceleration</strong>: seen in head compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01ca2f6239b443139c19f8cfb251123fx720x612.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Late deceleration</strong>:&nbsp;Seen in uteroplacental insufficiency, foetal hypoxia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d22f1efb031f427abc29cb814976ea47x468x323.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Variable</strong> <strong>deceleration</strong>: Seen in umbilical cord compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/034553eba0b7498882645a4cf156f0e0x468x399.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9801",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman brings her son to the hospital for routine immunization. While awaiting his turn, she realizes that her seat is stained with blood. She is rushed to the nearby antenatal clinic. Pulse - 96/min, BP - 110/80 mmHg. Vaginal bleeding is noted and her NST is shown below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Placenta previa"
        },
        {
          "id": 2,
          "text": "Vasa previa"
        },
        {
          "id": 3,
          "text": "Battledore placenta"
        },
        {
          "id": 4,
          "text": "Abruptio placentae"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario along with the NST showing a <strong>sinusoidal pattern</strong> point towards a diagnosis of<strong>&nbsp;vasa previa.&nbsp;</strong></p>\n<p>Vasa previa is a condition where&nbsp;<strong>fetal vessels</strong>&nbsp;travel within the&nbsp;membranes&nbsp;and <strong>overlie</strong> the <strong>cervical os</strong>. Hence, there can be <strong>bleeding</strong> during <strong>cervical dilatation</strong> or membrane rupture.&nbsp;</p>\n<p>Fetal mortality&nbsp;is high due to <strong>fetal exsanguination</strong>.&nbsp;When <strong>bleeding</strong> is present in vasa previa, an&nbsp;<strong>emergency cesarean</strong> section is indicated.</p>\n<p>Causes of<strong> sinusoidal pattern on NST</strong> include:</p>\n<ul>\n<li>Severe fetal anemia - Rh isoimmunisation, vasa previa, fetomaternal hemorrhage, or twin to twin transfusion</li>\n<li>Opioids - meperidine, morphine, alphaprodine, butorphanol</li>\n<li>Amnionitis</li>\n<li>Fetal distress&nbsp;</li>\n<li>Umbilical cord occlusion.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/82894d89bd5541d581e68b9bd6aba8abx1280x746.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b45d5d5ef2b74fec86ff586cd383bbdb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5695",
      "difficulty": "medium"
    }
  ]
}